The risk of Bell's Palsy, a type of facial paralysis, is higher after Sinovac Biotech Ltd's Covid-19 vaccine CoronaVac, but should not be a deterrent to vaccination, according to a study published in The Lancet Infectious Diseases journal.

"The beneficial and protective effects of the inactivated Covid-19 vaccine far outweigh the risk of this generally self-limiting adverse event," the study mentioned.

The study involved 28 clinically confirmed cases of Bell's Palsy after Sinovac's CoronaVac shot reported among nearly 452,000 individuals who received first dose of the vaccine, and 16 cases after Pfizer/BioNtech's vaccine...